GSK COPD Collaborative Research Project
Chronic obstructive pulmonary disease (COPD) is a serious, common and costly disease that can lead to frequent hospitalizations and death. In 2010, Missouri had one of the highest age-standardized death rates at 48-66 per 100,000 persons. COPD and its related conditions caused 528 deaths in St Louis City and County. According to the CDC, approximately 8.0% (age-adjusted = 7.6%) of Missouri residents surveyed in 2011 reported being told by a health care professional that they have COPD. Despite published guidelines, as few as 55% of ambulatory patients with COPD may be receiving proper care. Community pharmacists are well-positioned to assess medication adherence and assist in patient education and management.
Purpose of the Study
The purpose of this study is to evaluate the medication management of patients with COPD, at the community pharmacy level, by characterizing the severity of their disease and assessing the appropriateness of and adherence to their pharmacotherapy.
This trial will employ a cross-sectional study design and use validated questionnaires. Using standardized convenience sampling methods, subjects will be recruited by pharmacists in community pharmacies across the state of Missouri. A total of 875 subjects will be recruited from 35 pharmacies (roughly 25 subjects per pharmacy during a six-month period).
See detailed protocol under the Research Materials.
To learn more, review the list of participating pharmacies, read more about the grant team, or access resources for participating pharmacies.